Literature DB >> 18071674

Comparative studies of ZD0947, a novel ATP-sensitive K(+) channel opener, on guinea pig detrusor and aortic smooth muscles.

Takakazu Yunoki1, Hai-Lei Zhu, Kazuomi Iwasa, Toshihisa Tomoda, Manami Aishima, Atsushi Shibata, Seiji Naito, Noriyoshi Teramoto.   

Abstract

The effects of ZD0947, a novel urinary bladder selective ATP-sensitive potassium channel (K(ATP) channel) opener, on carbachol-induced contractions of isolated guinea pig urinary bladder strips were investigated to compare its ability to relax norepinephrine-induced contraction of the aorta. Electrophysiological techniques were also utilized to compare the effects of ZD0947 on membrane currents between guinea pig detrusor and aortic myocytes. ZD0947 caused a significant reduction of the carbachol-induced contractile activity, demonstrating a biphasic relaxation (the first and second components). Although glibenclamide antagonized the effects of two components for the ZD0947-induced relaxation, gliclazide, a selective sulphonylurea receptor 1 (SUR1) antagonist, reduced the effects of the first component but not the second component of the ZD0947-induced relaxation. ZD0947 also reduced the norepinephrine-induced contraction of the aorta. ZD0947 reduced electrical excitability of detrusor smooth muscles, inhibiting spike discharges and also hyperpolarizing the membrane as measured with microelectrodes. In conventional whole-cell configuration, ZD0947 caused a glibenclamide-sensitive K(+) current (i.e., K(ATP) current) at a holding potential of -60 mV in guinea pig detrusor and aortic myocytes. The current density of ZD0947-induced K(ATP) currents in guinea pig detrusor myocytes was significantly larger than that in aortic smooth muscle cells. These results show that ZD0947 caused a significant relaxation through the activation of K(ATP) channels in detrusor muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071674     DOI: 10.1007/s00210-007-0241-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

Review 1.  The overactive bladder: neuropharmacological basis of clinical management.

Authors:  J Sullivan; P Abrams
Journal:  Curr Opin Obstet Gynecol       Date:  1999-10       Impact factor: 1.927

Review 2.  Pharmacology of the lower urinary tract.

Authors:  W C de Groat; N Yoshimura
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

3.  The involvement of L-type Ca(2+) channels in the relaxant effects of the ATP-sensitive K(+) channel opener ZD6169 on pig urethral smooth muscle.

Authors:  N Teramoto; T Yunoki; S Ikawa; N Takano; K Tanaka; N Seki; S Naito; Y Ito
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Functional involvement of sulphonylurea receptor (SUR) type 1 and 2B in the activity of pig urethral ATP-sensitive K+ channels.

Authors:  Takakazu Yunoki; Noriyoshi Teramoto; Yushi Ito
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

5.  The effects of cromakalim on the detrusor muscle of human and pig urinary bladder.

Authors:  C D Foster; M J Speakman; K Fujii; A F Brading
Journal:  Br J Urol       Date:  1989-03

6.  Low levels of K(ATP) channel activation decrease excitability and contractility of urinary bladder.

Authors:  G V Petkov; T J Heppner; A D Bonev; G M Herrera; M T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-05       Impact factor: 3.619

7.  Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.

Authors:  F M Gribble; F M Ashcroft
Journal:  Diabetologia       Date:  1999-07       Impact factor: 10.122

8.  (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization.

Authors:  Michael E Brune; Thomas A Fey; Jorge D Brioni; James P Sullivan; Michael Williams; William A Carroll; Michael J Coghlan; Murali Gopalakrishnan
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

9.  The effect of cromakalim on the smooth muscle of the guinea-pig urinary bladder.

Authors:  C D Foster; K Fujii; J Kingdon; A F Brading
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

Review 10.  Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.

Authors:  Sharath S Hegde; Mathai Mammen; Jeffrey R Jasper
Journal:  Curr Opin Investig Drugs       Date:  2004-01
View more
  3 in total

Review 1.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

2.  The NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome Mediates Inflammation and Voiding Dysfunction in a Lipopolysaccharide-Induced Rat Model of Cystitis.

Authors:  Francis M Hughes; James G Kennis; Melissa N Youssef; Danielle W Lowe; Brooke E Shaner; J Todd Purves
Journal:  J Clin Cell Immunol       Date:  2016-02-29

3.  A biophysically constrained computational model of the action potential of mouse urinary bladder smooth muscle.

Authors:  Chitaranjan Mahapatra; Keith L Brain; Rohit Manchanda
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.